BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Health Canada Approves Next Pharmaceuticals' Relora®


4/2/2013 7:08:37 AM

SALINAS, CA--(Marketwire - April 01, 2013) - Health Canada has issued NPN 505349 for Relora, enabling the all-natural dietary supplement to be sold throughout Canada. Health Canada is the country's Federal department responsible for "helping Canadians maintain and improve their health" and rewarding these product licenses, required by all natural health products sold in Canada. Health Canada's review process is highly selective to ensure the quality of products sold throughout the country.

Relora, sold in the US since 2000 (US Patent No. 6,582,735), alleviates stress, curbs stress-related eating and promotes weight management by quieting the hypothalamic-pituitary-adrenal axis without causing drowsiness. Relora's ingredients, a blend of Magnolia officinalis and Phellodendron amurense bark extracts are botanicals that have been used in Traditional Chinese Medicine for thousands of years. In the West, they have been recognized for treating stress. When compared to prescription drugs, Honokiol and Berberine appear effective at calming stress and anxiety without sedative side effects. Relora is Kosher certified by KOF-K (Certification No. 2V04W-QQWYC).

Relora is the leading supplement in its category in the US. Widely accepted by the medical community, Relora has been frequently cited in the industry and mainstream media, being recognized in Better Nutrition Magazine's Top 12 of 2012 as an "up-and-coming superstar" and featured twice on the US' leading national TV health program as one of the Best Belly-Blasting Supplements and as part of the Flat Belly Plan.

Relora is a powder available for use in capsule form for oral administration. Relora is a product of Next Pharmaceuticals. Companies located in Canada can purchase Relora through Next Pharmaceuticals' exclusive distributor, EnZed Nutricorp.

Next Pharmaceuticals develops innovative, natural raw materials for the dietary supplement, food and beverage industries. With a goal of delivering patented, branded, clinically tested ingredients to help the consumer lead healthier lives, the company is committed to clinical research and offering the highest quality ingredients available. Next ingredients help consumers cope with many of today's most prevalent and chronic health issues by significantly expanding the choices for self-care products. At the same time, they provide consumer brands with powerful product differentiation. Next Pharmaceutical ingredients can now be found in the finest consumer brands throughout the US and Canada.

For more information on NextPharmaceuticals, visit www.NextPharmaceuticals.com.

Contact:

Contact information

Ashley Beleny

Environmental Relations PR

(831) 649-2334

ashley@enviro-rel.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES